Efficacy of Venlafaxine and Methylphenidate in the Treatment of Children with Attention Deficit Hyperactivity Disorder

AUTHORS

Mahbobe Firoozkoohi moghaddam 1 , fariba Arabgol 2 , * , Sepideh Rajezi 3 , Jamal Shams 4

1 Dept of Psychology, Faculty of Medicine, Zahedan University of Medical Sciences and Health Services, Zahedan, Iran

2 Behavior Research Center, Shahid Beheshti University of Medical Sciences and Health Services, Teharn, Iran

3 Dept of Psychology, Faculty of Medicine, Shahid Beheshti University of Medical Sciences and Health Services, Teharn, Iran

4 Neurology Research Center, Shahid Beheshti University of Medical Sciences and Health Services, Teharn, Iran

How to Cite: Firoozkoohi moghaddam M, Arabgol F, Rajezi S, Shams J. Efficacy of Venlafaxine and Methylphenidate in the Treatment of Children with Attention Deficit Hyperactivity Disorder , Zahedan J Res Med Sci. 2003 ; 5(2):e95139.

ARTICLE INFORMATION

Zahedan Journal of Research in Medical Sciences: 5 (2); e95139
Published Online: June 26, 2003
Article Type: Research Article
Received: May 23, 2003
Accepted: June 24, 2003
READ FULL TEXT

Abstract

Background The role of noradrenergic system is strongly considered in etiology and treatment of attention deficit hyperactivity disorder (ADHD). Regarding the role of norepinephrin and serotonin neurotransmitters in activity and attention control processes, this study was performed to compare effectiveness of venlafaxine and methylphenidate in the treatment of ADHD.

  Materials and Methods: Forty children with ADHD (aged 6-12) were randomly allocated to receive venlafaxine or methylphenidate in a 6-week clinical trial in Emam-Hossein Hospital. There were no significant differences between groups for age, weight, type and severity of the disorder. Based on DSM-IV criteria and ADHD Rating Scale, patients were diagnosed as having combined and inattentive types of ADHD. Treatment outcome was assessed using parent and teacher versions of ADHD Rating Scale in weeks 2, 4 and 6.

  Results: There was a statistically significant decrease in ADHD Rating Scale scores and clinical improvement in each group and there was significant difference between the two groups. The most common adverse effects in venlafaxine group were nausea, sedation, dry mouth and dizziness.

  Conclusion: Venlafaxine is effective in the treatment of children with ADHD and could be used as a safe drug in these children through further studies with greater sample sizes are needed to confirm these results.

Fulltext

References

  • 1.

    The References of this article are available on the PDF file.

  • © 2003, Zahedan Journal of Research in Medical Sciences. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
    COMMENTS

    LEAVE A COMMENT HERE:

    READER'S COMMENTS

    avatar

    Jiwoo Suk says:

    Thank you for your help.